Literature DB >> 9525645

The bovine leukemia virus encapsidation signal is composed of RNA secondary structures.

L M Mansky1, R M Wisniewski.   

Abstract

The encapsidation signal of bovine leukemia virus (BLV) was previously shown by deletion analysis to be discontinuous and to extend into the 5' end of the gag gene (L. Mansky et al., J. Virol. 69:3282-3289, 1995). The global minimum-energy optimal folding for the entire BLV RNA, including the previously mapped primary and secondary encapsidation signal regions, was analyzed. Two stable stem-loop structures (located just downstream of the gag start codon) were predicted within the primary signal region, and one stable stem-loop structure (in the gag gene) was predicted in the secondary signal region. Based on these predicted structures, we introduced a series of mutations into the primary and secondary encapsidation signals in order to explore the sequence and structural information contained within these regions. The replication efficiency and levels of cytoplasmic and virion RNA were analyzed for these mutants. Mutations that disrupted either or both of the predicted stem-loop structures of the primary signal reduced the replication efficiency by factors of 7 and 40, respectively; similar reductions in RNA encapsidation efficiency were observed. The mutant with both stem-loop structures disrupted had a phenotype similar to that of a mutant containing a deletion of the entire primary signal region. Mutations that disrupted the predicted stem-loop structure of the secondary signal led to similar reductions (factors of 4 to 6) in both the replication and RNA encapsidation efficiencies. The introduction of compensatory mutations into mutants from both the primary and secondary signal regions, which restored the predicted stem-loop structures, led to levels of replication and RNA encapsidation comparable to those of virus containing the wild-type encapsidation signal. Replacement of the BLV RNA region containing the primary and secondary encapsidation signals with a similar region from human T-cell leukemia virus (HTLV) type 1 or type 2 led to virus replication at three-quarters or one-fifth of the level of the parental virus, respectively. The results from both the compensatory mutants and BLV-HTLV chimeras indicate that the encapsidation sequences are recognized largely by their secondary or tertiary structures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525645      PMCID: PMC109782     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  An avian oncovirus mutant deficient in genomic RNA: characterization of the packaged RNA as cellular messenger RNA.

Authors:  B Gallis; M Linial; R Eisenman
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

2.  A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro.

Authors:  E Bieth; C Gabus; J L Darlix
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

3.  Studies on carcinogenesis by avian sarcoma viruses. 8. Glycolysis and cell multiplication.

Authors:  H M Temin
Journal:  Int J Cancer       Date:  1968-03-15       Impact factor: 7.396

4.  Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information.

Authors:  M Zuker; P Stiegler
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

5.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  Identification of a sequence likely to be required for avian retroviral packaging.

Authors:  T Pugatsch; D W Stacey
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

7.  cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus.

Authors:  J Sorge; W Ricci; S H Hughes
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

8.  Human T-cell leukemia virus type II transforms normal human lymphocytes.

Authors:  I S Chen; S G Quan; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5' long terminal repeat and the start of the gag gene.

Authors:  S Watanabe; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  13 in total

1.  In vitro characterization of a base pairing interaction between the primer binding site and the minimal packaging signal of avian leukosis virus genomic RNA.

Authors:  Igor Kanevsky; Natalya Vasilenko; Hélène Dumay-Odelot; Philippe Fossé
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

2.  Human T-cell leukemia virus type 1 Gag domains have distinct RNA-binding specificities with implications for RNA packaging and dimerization.

Authors:  Weixin Wu; Joshua Hatterschide; Yu-Ci Syu; William A Cantara; Ruth J Blower; Heather M Hanson; Louis M Mansky; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

Review 3.  Beyond plasma membrane targeting: role of the MA domain of Gag in retroviral genome encapsidation.

Authors:  Leslie J Parent; Nicole Gudleski
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

4.  Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging.

Authors:  Huating Wang; Kendra M Norris; Louis M Mansky
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Analysis of bovine leukemia virus gag membrane targeting and late domain function.

Authors:  Huating Wang; Kendra M Norris; Louis M Mansky
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release.

Authors:  Huating Wang; Nicholas J Machesky; Louis M Mansky
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Transmissible gastroenteritis coronavirus genome packaging signal is located at the 5' end of the genome and promotes viral RNA incorporation into virions in a replication-independent process.

Authors:  Lucia Morales; Pedro A Mateos-Gomez; Carmen Capiscol; Lorena del Palacio; Luis Enjuanes; Isabel Sola
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

8.  Retrovirus-specific differences in matrix and nucleocapsid protein-nucleic acid interactions: implications for genomic RNA packaging.

Authors:  Meng Sun; Iwen F Grigsby; Robert J Gorelick; Louis M Mansky; Karin Musier-Forsyth
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

9.  Biochemical characterization of a structure-specific resolving enzyme from Sulfolobus islandicus rod-shaped virus 2.

Authors:  Andrew F Gardner; Chudi Guan; William E Jack
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

10.  Identification of a high affinity nucleocapsid protein binding element from the bovine leukemia virus genome.

Authors:  F Zehra Yildiz; Kathlene Babalola; Michael F Summers
Journal:  Virus Res       Date:  2012-07-27       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.